Sign in
4

Changes in Ownership

RIGEL PHARMACEUTICALS INC Filed Acc 0001140361-23-034288

Director acquired 25,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Wasman Jane Director 2023-05-26 Grant or award +25,000 75,000 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Wasman Jane Director 2023-05-26 Grant or award · Stock Option (Right to Buy) +30,000 30,000 D: show line 2 in the form
Loading xslF345X04/form4.xml…